Augmedix Stock Cash And Equivalents
| AUGXDelisted Stock | USD 2.35 0.00 0.00% |
Augmedix fundamentals help investors to digest information that contributes to Augmedix's financial success or failures. It also enables traders to predict the movement of Augmedix Stock. The fundamental analysis module provides a way to measure Augmedix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Augmedix stock.
Augmedix |
Augmedix Company Cash And Equivalents Analysis
Augmedix's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Augmedix Cash And Equivalents | 29.99 M |
Most of Augmedix's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Augmedix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Augmedix has 29.99 M in Cash And Equivalents. This is 96.35% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The cash and equivalents for all United States stocks is 98.89% higher than that of the company.
Augmedix Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Augmedix's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Augmedix could also be used in its relative valuation, which is a method of valuing Augmedix by comparing valuation metrics of similar companies.Augmedix is currently under evaluation in cash and equivalents category among its peers.
Augmedix Fundamentals
| Return On Equity | -3.3 | |||
| Return On Asset | -0.31 | |||
| Profit Margin | (0.46) % | |||
| Operating Margin | (0.64) % | |||
| Current Valuation | 113.21 M | |||
| Shares Outstanding | 49.43 M | |||
| Shares Owned By Insiders | 1.50 % | |||
| Shares Owned By Institutions | 84.78 % | |||
| Number Of Shares Shorted | 1.07 M | |||
| Price To Book | 11.09 X | |||
| Price To Sales | 2.25 X | |||
| Revenue | 44.85 M | |||
| Gross Profit | 13.95 M | |||
| EBITDA | (17.68 M) | |||
| Net Income | (19.17 M) | |||
| Cash And Equivalents | 29.99 M | |||
| Cash Per Share | 0.80 X | |||
| Total Debt | 25.85 M | |||
| Debt To Equity | 1.54 % | |||
| Current Ratio | 2.89 X | |||
| Book Value Per Share | 0.21 X | |||
| Cash Flow From Operations | (15.44 M) | |||
| Short Ratio | 5.73 X | |||
| Earnings Per Share | (0.47) X | |||
| Target Price | 2.92 | |||
| Number Of Employees | 1.43 K | |||
| Beta | -0.19 | |||
| Market Capitalization | 116.16 M | |||
| Total Asset | 66.71 M | |||
| Retained Earnings | (144.96 M) | |||
| Working Capital | 33.2 M | |||
| Net Asset | 66.71 M |
About Augmedix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Augmedix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Augmedix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Augmedix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Augmedix Stock
If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |